|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Medicine and Mount Sinai Bone Program, Mount Sinai School of Medicine, New York, New York, United States
2 Endocrinology, Mount Sinai, New York, New York, United States
* To whom correspondence should be addressed. E-mail: mone.zaidi{at}mssm.edu.
Here we demonstrate that the Ca2+/calmodulin-sensitive phosphatase calcineurin is a necessary downstream mediator for osteoclast differentiation. Using quantitative PCR (qPCR), we detected all calcineurin isoforms, namely A
, A
, A
(catalytic) and B1 and B2 (regulatory) in osteoclast precursor RAW-C3 cells. We found that while the expression of these isoforms remained relatively unchanged during osteoclast differentiation, there was a profound increase in the expression of their primary substrate for calcineurin, NFATc1. For gain-of-function studies, we incubated osteoclast precursors for 10 minutes with a calcineurin fusion protein, TAT-calcineurin A
, this resulted in its receptor-less influx into >90% of the precursor cells. A marked increase in the expression of the osteoclast differentiation markers tartrate-resistant acid phosphatase (TRAP) and integrin
3 followed. In addition, the expression of NFATc1, as well as the alternative substrate for calcineurin, I
B
, was enhanced significantly. Likewise, transfection with constitutively active NFAT (NFATca) resulted in an increased expression of both TRAP and
3. In parallel loss-of-function studies, transfection with dominant-negative NFAT (NFATdnnot only inhibited osteoclast formation, but also reversed the induction of NFATc1, TRAP and
3 by TAT-calcineurin A
. The expression of these markers was also inhibited by calcineurin A
U1 snRNA. Consistent with these observations, we also observed a reduction in osteoclastogenesis in calcineurin A
-\- cells, as well as in osteoclast precursors treated with the calcineurin inhibitors, cyclosporine A and FK506. Together the gain- and loss-of-function experiments establish that calcineurin A
is necessary for osteoclast formation from its precursor, and that this occurs via an NFATc1-dependent mechanism.
This article has been cited by other articles:
![]() |
S. Yang and Y.-P. Li RGS10-null mutation impairs osteoclast differentiation resulting from the loss of [Ca2+]i oscillation regulation Genes & Dev., July 15, 2007; 21(14): 1803 - 1816. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |